Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 168

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 168
---
 challenges. Consequently, there is some risk
of any data transfers from the EU being halted. If we have to rely on third parties to carry out services for us, including processing
personal data on our behalf, we are required under GDPR to enter into contractual arrangements to flow down or help ensure that these
third parties only process such data according to our instructions and have sufficient security measures in place. Any security breach
or non-compliance with our contractual terms or breach of applicable law by such third parties could result in enforcement actions, litigation,
fines and penalties or adverse publicity and could cause customers to lose trust in us, which would have an adverse impact on our reputation
and business. Any contractual arrangements requiring the processing of personal data from the EU to us in the U.S. will require greater
scrutiny and assessments as required under Schrems II and may have an adverse impact on cross-border transfers of personal data or increase
costs of compliance.

Applicable data privacy and data protection laws
may conflict with each other, and by complying with the laws or regulations of one jurisdiction, we may find that we are violating the
laws or regulations of another jurisdiction. Despite our efforts, we may not have fully complied in the past and may not in the future.
That could require us to incur significant expenses, which could significantly affect our business. Failure to comply with data protection
laws may expose us to risk of enforcement actions taken by data protection authorities or other regulatory agencies, private rights of
action in some jurisdictions, and potential significant penalties if we are found to be non-compliant. Furthermore, the number of government
investigations related to data security incidents and privacy violations continue to increase and government investigations typically
require significant resources and generate negative publicity, which could harm our business and reputation.

67

Our business activities may be subject to the Foreign Corrupt
Practices Act (“FCPA”) and similar anti-bribery and anti-corruption laws of other countries in which we operate.

We intend to initiate studies in countries other
than the United States. Our business activities may be subject to the FCPA and similar anti-bribery or anti-corruption laws, regulations
or rules of other countries in which we operate. The FCPA generally prohibits offering, promising, giving or authorizing others to give
anything of value, either directly or indirectly, to a non-U.S. government official in order to influence official action or otherwise
obtain or retain business. The FCPA also requires public companies